Value proposition

Building the future of cell-based therapies.

CAR-T is for more than just oncology. Using the full potential of gene editing, we are creating a therapeutic platform for cell based therapies that are not just disease modifying: they are curative and definitive.

Cell-based Therapies and Machine Learning